REG - GlaxoSmithKline PLC - Total Voting Rights

GSKAnnouncement

02/01/2020 10:00

RNS Number : 5386Y
GlaxoSmithKline PLC
02 January 2020
 


GlaxoSmithKline plc
 
Total Voting Rights and Capital
 
In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:
 
The Company's issued share capital as at 31 December 2019 consisted of 5,383,102,231 shares of 25 pence each ('Ordinary Shares'), of which 393,505,950 Ordinary Shares were held in Treasury.
 
Therefore, the total number of voting rights in the Company is 4,989,596,281. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
 
 
 
 
V A Whyte
Company Secretary
 
2 January 2020
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRUPUQAGUPUUBP